Supply

Supply and/or administration of Controlled Drugs under a PGD

2 June 2025The legal position on the supply and/or administration of controlled drugs under Patient Group Directions is summarised

Off label medicine use under a Patient Group Direction

2 June 2025This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Unlicensed medicines and use of PGDs

2 June 2025This page explains why PGDs are not a legal mechanism for the administration or supply of unlicensed medicines.

Labelling and packaging medicines supplied by dental teams

26 March 2025Requirements for labelling and packaging medicines before supply by dental teams are detailed in legislation and depend on the classification of the medicine

Supplying medical devices: advice for dental teams

26 March 2025Advice on supplying medical devices directly to NHS and private patients by dentists, dental hygienists and dental therapists.

Supplying P and GSL medicines: advice for dental teams

26 March 2025Advice on supplying P and GSL medicines to NHS and private patients by dentists, dental hygienists and dental therapists.

Supplying Prescription Only Medicines: advice for dental teams

26 March 2025Advice on supplying prescription only medicines (POMs) to NHS and private patients by dentists, dental hygienists and dental therapists.

Supplying medicines and medical devices: advice for dental teams

26 March 2025Supply of medicines by dentists and dental care professionals depends on the class of medicine, legal mechanism used and requires a local governance framework.

Prescribing GLP-1 receptor agonists

26 March 2025Glucagon-like peptide-1 (GLP-1) receptor agonist availability is resolved. Supply content is maintained by DHSC.

Prescribing and using thiamine to prevent refeeding syndrome

11 March 2025Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.